Trial Profile
Hepatic Metabolic Changes in Response to Glucagon Infusion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2021
Price :
$35
*
At a glance
- Drugs Glucagon (Primary)
- Indications Non-alcoholic fatty liver disease; Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 05 Jul 2019 Status changed from recruiting to completed.
- 18 May 2018 New trial record